Decoy Therapeutics Inc
DCOY
NASDAQ
Biotechnology
$3.58
USD
+0.05 (+1.42%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $2.07M
Volume 13.2K
Revenue
—
TTM
— YoY
Gross Margin
—
TTM
— YoY
Net Income
—
TTM
— YoY
Operating Cash Flow
—
TTM
— YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q1 2026 | Q2 2026 |
|---|---|---|
Revenue | 0.0 | 0.2 |
YoY Growth | — | — |
Cost of Revenue | 0.0 | 0.0 |
Gross Profit | 0.0 | 0.2 |
Selling, General & Administrative | 1.5 | 1.3 |
Other Operating Expenses | 0.0 | 0.0 |
Total Operating Expenses | 2.3 | 2.6 |
Operating Income | -2.3 | -2.4 |
EBITDA | -2.3 | -2.4 |
Other Income / Expense | 0.0 | 0.0 |
Total Other Income / Expense | 0.1 | 0.0 |
Income Before Income Taxes | -2.2 | -2.4 |
Income Taxes | 0.0 | 0.0 |
Net Income | -2.2 | -2.4 |
Consolidated Net Income / Loss | -2.2 | -2.4 |
Net Income Attributable to Common Shareholders | -2.2 | -2.4 |
Basic EPS | -$4.18 | -$4.46 |
Diluted EPS | -$4.18 | -$4.46 |
Basic Shares Outstanding | 0.5M | 0.5M |
Diluted Shares Outstanding | 0.5M | 0.5M |